(Q54067573)
Statements
Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 mono- clonal antibody) and interleukin-2. (English)
1 reference
Keilholz U
1 reference
Szelényi H
1 reference
Siehl J
1 reference
Foss HD
1 reference
Knauf W
1 reference
Thiel E
1 reference
1 November 1999
1 reference
35
1 reference
641-642
1 reference
5-6
1 reference
Identifiers
1 reference